Vaccinated kidney transplant recipients are yet not sufficiently protected against COVID-19

por Messchendorp, A Lianne, Gansevoort, Ron T
Publicado 2023

CKD is a key risk factor for COVID-19 mortality

por Gansevoort, Ron T., Hilbrands, Luuk B.
Publicado 2020

Sodium-glucose cotransporter 2 inhibitors: extending the indication to non-diabetic kidney disease?

por Dekkers, Claire C J, Gansevoort, Ron T
Publicado 2020

Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease

por Bais, Thomas, Gansevoort, Ron T., Meijer, Esther
Publicado 2022

Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association

por Ortiz, Alberto, Wanner, Christoph, Gansevoort, Ron
Publicado 2022

Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association

por Ortiz, Alberto, Wanner, Christoph, Gansevoort, Ron
Publicado 2022

No Change in Nocturia After NOCTURNE

por Meijer, Esther, Heida, Judith E., Gansevoort, Ron T.
Publicado 2020

Acid-Base Homeostasis During Vasopressin V2 Receptor Antagonist Treatment in Autosomal Dominant Polycystic Kidney Disease Patients

por Heida, Judith E., Gansevoort, Ron T., Meijer, Esther
Publicado 2021

Author’s Reply to Correspondence: “Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients”

por Heida, Judith E., Gansevoort, Ron T., Meijer, Esther
Publicado 2021

Informing clinical decision making during a pandemic — a call for better preparedness

por Vart, Priya, Hilbrands, Luuk B., Gansevoort, Ron T.
Publicado 2023

New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors

por Dekkers, Claire C. J., Gansevoort, Ron T., Heerspink, Hiddo J. L.
Publicado 2018

Somatostatin in renal physiology and autosomal dominant polycystic kidney disease

por Messchendorp, A Lianne, Casteleijn, Niek F, Meijer, Esther, Gansevoort, Ron T
Publicado 2019

Development and implementation of work-oriented clinical care to empower patients with kidney disease: an adapted intervention mapping approach

por de Vries, Haitze J., Sipma, Wim S., Gansevoort, Ron T., Brouwer, Sandra, Visser, Annemieke
Publicado 2023

Reference Data for the Ruff Figural Fluency Test Stratified by Age and Educational Level

por Izaks, Gerbrand J., Joosten, Hanneke, Koerts, Janneke, Gansevoort, Ron T., Slaets, Joris P.
Publicado 2011

Case report: a thiazide diuretic to treat polyuria induced by tolvaptan

por Kramers, Bart J., van Gastel, Maatje D. A., Meijer, Esther, Gansevoort, Ron T.
Publicado 2018

Body fat estimates from bioelectrical impedance equations in cardiovascular risk assessment: The PREVEND cohort study

por Byambasukh, Oyuntugs, Eisenga, Michele F, Gansevoort, Ron T, Bakker, Stephan JL, Corpeleijn, Eva
Publicado 2019

The association of glucagon with disease severity and progression in patients with autosomal dominant polycystic kidney disease: an observational cohort study

por Knol, Martine G E, Kramers, Bart J, Gansevoort, Ron T, van Gastel, Maatje D A
Publicado 2021

The Association of Albuminuria With Tubular Reabsorption of Uric Acid: Results From a General Population Cohort

por Scheven, Lieneke, Joosten, Michel M., de Jong, Paul E., Bakker, Stephan J. L., Gansevoort, Ron T.
Publicado 2014

Heart Rate Variability and Its Relation to Chronic Kidney Disease: Results From the PREVEND Study

por Thio, Christian H.L., van Roon, Arie M., Lefrandt, Joop D., Gansevoort, Ron T., Snieder, Harold
Publicado 2018

Effect of a Somatostatin Analogue on the Vasopressin Pathway in Patients With ADPKD

por Messchendorp, A. Lianne, Kramers, Bart J., Spithoven, Edwin M., Stade, Katrin, Meijer, Esther, Gansevoort, Ron T.
Publicado 2019